肿瘤血管生成：癌症治疗的关键靶点。 - Suppr

Suppr

超能文献

Tumor Angiogenesis: A Key Target for Cancer Therapy.

作者信息

Marmé Dieter

出版信息

Oncol Res Treat. 2018;41(4):164. doi: 10.1159/000488340. Epub 2018 Mar 28.

DOI:10.1159/000488340

PMID:29587285

Abstract

摘要

相似文献

Tumor Angiogenesis: A Key Target for Cancer Therapy.肿瘤血管生成：癌症治疗的关键靶点。

Oncol Res Treat. 2018;41(4):164. doi: 10.1159/000488340. Epub 2018 Mar 28.

Molecular-targeted therapy for cancer.癌症的分子靶向治疗

Chin J Cancer. 2010 Mar;29(3):340-5. doi: 10.5732/cjc.009.10313.

Therapeutic targeting of the tumor vasculature.肿瘤血管系统的治疗性靶向作用。

Semin Radiat Oncol. 2004 Jul;14(3):222-32. doi: 10.1016/j.semradonc.2004.04.009.

Novel agents target existing tumor vasculature.新型药物靶向现有肿瘤血管。

Expert Rev Anticancer Ther. 2010 Mar;10(3):303.

Closing in on cancer.向癌症逼近。

Time. 2001 May 21;157(20):60, 62.

Angiogenesis. A boost for tumor starvation.血管生成。肿瘤饥饿疗法的一大助力。

Science. 2003 Jul 25;301(5632):452-4. doi: 10.1126/science.301.5632.452.

Rationale, problems and perspectives in anti-angiogenic therapy.抗血管生成治疗的基本原理、问题及前景

Tumori. 2001 Nov-Dec;87(6):S17-9.

Endostatin: are the 2 years up yet?内皮抑素：两年时间到了吗？

J Clin Oncol. 2002 Sep 15;20(18):3758-60. doi: 10.1200/JCO.2002.20.18.3758.

Natural compounds show antiangiogenic activity.天然化合物具有抗血管生成活性。

J Natl Cancer Inst. 2001 Nov 21;93(22):1685. doi: 10.1093/jnci/93.22.1685.

Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.当前癌症个体化抗血管生成治疗的关注点与挑战。

Expert Rev Anticancer Ther. 2009 Oct;9(10):1413-6. doi: 10.1586/era.09.116.

引用本文的文献

Efficacy and safety of first-line treatment options for advanced non-small cell lung cancer: A retrospective study.晚期非小细胞肺癌一线治疗方案的疗效与安全性：一项回顾性研究。

Medicine (Baltimore). 2025 Jul 25;104(30):e43300. doi: 10.1097/MD.0000000000043300.

Hemorrhagic and ischemic risks of anti-VEGF therapies in glioblastoma.胶质母细胞瘤中抗血管内皮生长因子（VEGF）治疗的出血和缺血风险

Cancer Gene Ther. 2025 May 21. doi: 10.1038/s41417-025-00914-8.

Polydatin inhibits the stemness and angiogenesis of gastric cancer cells by targeting down-regulation of HDAC7.虎杖苷通过靶向下调HDAC7抑制胃癌细胞的干性和血管生成。

Discov Oncol. 2025 May 14;16(1):761. doi: 10.1007/s12672-025-02481-8.

DRIM modulates Src activation and regulates angiogenic functions in vascular endothelial cells.DRIM调节Src激活并调控血管内皮细胞的血管生成功能。

Cell Biol Int. 2025 Mar;49(3):277-287. doi: 10.1002/cbin.12265. Epub 2024 Dec 8.

HMGB1/RAGE axis in tumor development: unraveling its significance.肿瘤发展中的HMGB1/RAGE轴：揭示其重要性

Front Oncol. 2024 Mar 1;14:1336191. doi: 10.3389/fonc.2024.1336191. eCollection 2024.

Anticancer activities of natural antimicrobial peptides from animals.动物源天然抗菌肽的抗癌活性

Front Microbiol. 2024 Jan 17;14:1321386. doi: 10.3389/fmicb.2023.1321386. eCollection 2023.

Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib.安罗替尼不良反应作用机制与管理研究进展。

Drug Des Devel Ther. 2023 Nov 15;17:3429-3437. doi: 10.2147/DDDT.S426898. eCollection 2023.

Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management.动脉粥样硬化、糖尿病和癌症：共同的流行病学、共同的机制和未来的管理。

Int J Mol Sci. 2023 Jul 22;24(14):11786. doi: 10.3390/ijms241411786.

The Relation of VEGFA, VEGFR2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with Breast Cancer in Egyptian Patients.埃及患者乳腺癌与 VEGFA、VEGFR2、VEGI 和 HIF1A 基因变异及其血清蛋白水平的关系。

Biochem Genet. 2024 Feb;62(1):547-573. doi: 10.1007/s10528-023-10419-4. Epub 2023 Jul 1.

Antiangiogenic Activity of n-hexane Insoluble Fraction and Its Tylophorine Component from Ficus septica Leaves in Chicken Chorioallantoic Membrane Induced by bFGF.相思树叶正己烷不溶部分及其所含远志呫吨酮成分抗 bFGF 诱导鸡胚尿囊膜血管生成活性

Asian Pac J Cancer Prev. 2023 Jan 1;24(1):75-80. doi: 10.31557/APJCP.2023.24.1.75.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验